Skip to main content
. 2024 Jun 12;16(12):2201. doi: 10.3390/cancers16122201
WHO World Health Organization
CNS Central nervous system
ALL Acute lymphoblastic leukemia
AML Acute myeloid leukemia
JAK Janus kinases
STAT Signal transducer and activator of transcription
PI3K Phosphoinositide 3-kinases
ALK Anaplastic lymphoma kinase
NF1 Neurofibromatosis type 1
PTEN Phosphatase and tensin homolog
FLT3 FMS-like tyrosine kinase 3
PIK3CA Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha or p110α
PIK3R1 Phosphoinositide-3-kinase regulatory subunit 1
CDKN2A Cyclin-dependent kinase Inhibitor 2A
TME Tumor microenvironment
TILs Tumor-infiltrating lymphocytes
Tregs Regulatory T cells
NK cells Natural killer cells
DCs Dendritic cells
MDSCs Myeloid-derived suppressor cells
ECM Extracellular matrix
mAbs Monoclonal antibodies
CAR Chimeric antigen receptor
TAMs Tumor-associated macrophages
TMB Tumor mutational burden
LGG Low-grade gliomas
HGG High-grade gliomas
IFNγ Interferon-gamma
CSF1R Colony stimulating factor 1 receptor
CTLs Cytotoxic T lymphocytes
PMN Polymorphonuclear
PD-L1 Programmed death ligand-1
IL6 Interleukin 6
ES Ewing sarcoma
TNF-α Tumor necrosis factor-alpha
CTLA-4 Cytotoxic T-lymphocyte-associated protein 4
PD-1 Programmed cell death protein 1
MRD Minimal residual disease
HSCT Hematopoietic stem cell transplantation
GM-CSF Granulocyte-macrophage colony-stimulating factor
SCT Stem-cell transplantation
COG Children’s oncology group
ADCC Antibody-dependent cellular cytotoxicity